Government makes a mockery of PHARMAC review

3 November 2021 - “The ACT Party can today reveal the review into PHARMAC has been delayed by more than ...

Read more →

Major PHARMAC review delayed nearly 3 months

3 November 2021 - A major review into Government drug buying agency PHARMAC has been delayed by nearly three months. ...

Read more →

Where is the PHARMAC Review Panel’s interim report?

12 October 2021 - Patient advocacy groups and clinicians are calling out the PHARMAC Review Panel for failing to get their ...

Read more →

OIA documents prove PHARMAC's independent inquiry is a toothless whitewash

11 October 2021 - Following a damning survey of PHARMAC, National can also reveal documents received under OIA show the ...

Read more →

Review of the National Medicines Policy

11 October 2021 - The call for submissions closed on Friday 8 October 2021 and a total of 107 submissions have ...

Read more →

Where has PHARMAC gone?

7 October 2021 - As debate has intensified over the last year or so about the procurement of New Zealand’s ...

Read more →

U.S. Food and Drug Administration reasoning in approval decisions when efficacy evidence is borderline (2013–2018)

21 September 2021 - The U.S. FDA has substantial flexibility in its approval criteria in the context of life-threatening disease and ...

Read more →

Covid-19 delta outbreak: major PHARMAC review report delayed by lockdown

22 September 2021 - Act says it is "not good enough" an interim report for a much touted independent PHARMAC ...

Read more →

EU-HTA regulation: methodical preparations for implementation start with IQWiG and G-BA

21 September 2021 - The institute and the G-BA are part of a consortium that is developing the methodological basis ...

Read more →

Final report on the Australian Government response to the recommendations of the Senate Community Affairs References Committee Report

15 September 2021 - The Government acknowledges the efforts and actions detailed in this progress report to implement the Senate ...

Read more →

Medicare Benefits Schedule continuous review to improve patient care

13 September 2021 - Medicare items and services will be reviewed by experts on an on-going basis to ensure the Medicare ...

Read more →

Review of the National Medicines Policy – call for submissions

30 August 2021 - The National Medicines Policy Review Committee is now welcoming submissions to support the review of the National Medicines ...

Read more →

Method paper: IQWiG puts draft version 6.1 up for discussion

23 August 2021 - The IQWiG has presented the draft for the next version of its General Methods.  ...

Read more →

NICE’s health technology assessment methods and processes to be evaluated

19 August 2021 - NICE has launched a public consultation on proposed changes to the way it develops recommendations across ...

Read more →

Congress should fix FDA’s accelerated approval program for the next 30 years

12 August 2021 - The FDA's approval of the Alzheimer’s drug Aduhelm has sparked a broader debate on the merits ...

Read more →